Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Transplanted hair follicles can change and adapt to new areas of the body, with the immune system possibly playing a role in this adjustment.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Ethosomes are a promising method for treating hair loss by delivering drugs directly to the scalp.

Different hair growth phases affect how follicles respond to X-rays, and hormones like testosterone and dihydrotestosterone play a key role in baldness; transplanted hair can grow on bald scalp areas.

Topical Valproate is safe for human skin and unlikely to cause irritation.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Hair loss in men is common, treatable, but not curable.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.

Hair follicle culture helps develop new treatments for hair loss.

Mesotherapy for hair loss can sometimes cause more hair loss and scarring.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Both methods improve hair density and thickness; double-spin may be more effective.

A man developed unusual growths after a hair transplant, which were treated successfully with no recurrence after a month.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."